实验性游离配体构象：基于结构的药物发现中缺失的环节。 - Suppr

Suppr

超能文献

Experimental free ligand conformations: a missing link in structure-based drug discovery.

作者信息

Chiarparin Elisabetta, Packer Martin J, Wilson David M

机构信息

Medicinal Chemistry, Oncology, IMED Biotech Unit, AstraZeneca, Cambridge, UK.

Medicinal Chemistry, Oncology, IMED Biotech Unit, AstraZeneca, Alderley Park, UK.

出版信息

Future Med Chem. 2019 Jan;11(2):79-82. doi: 10.4155/fmc-2018-0339. Epub 2019 Jan 16.

DOI:10.4155/fmc-2018-0339

PMID:30648432

Abstract

摘要

相似文献

Experimental free ligand conformations: a missing link in structure-based drug discovery.

Future Med Chem. 2019 Jan;11(2):79-82. doi: 10.4155/fmc-2018-0339. Epub 2019 Jan 16.

Mass spectrometry for fragment screening.

Essays Biochem. 2017 Nov 8;61(5):465-473. doi: 10.1042/EBC20170071.

Counting on Fragment Based Drug Design Approach for Drug Discovery.

Curr Top Med Chem. 2018;18(27):2284-2293. doi: 10.2174/1568026619666181130134250.

NMR spectroscopy: the swiss army knife of drug discovery.

J Biomol NMR. 2020 Nov;74(10-11):509-519. doi: 10.1007/s10858-020-00330-0. Epub 2020 Jul 2.

NMR in structure-based drug design.

Essays Biochem. 2017 Nov 8;61(5):485-493. doi: 10.1042/EBC20170037.

Fragment-based lead discovery and design.

J Chem Inf Model. 2014 Mar 24;54(3):693-704. doi: 10.1021/ci400731w. Epub 2014 Feb 19.

The conformational musings of a medicinal chemist.

Drug Discov Today. 2014 Mar;19(3):320-5. doi: 10.1016/j.drudis.2013.10.016. Epub 2013 Oct 31.

The use of small-molecule structures to complement protein-ligand crystal structures in drug discovery.

Acta Crystallogr D Struct Biol. 2017 Mar 1;73(Pt 3):240-245. doi: 10.1107/S2059798317000675. Epub 2017 Feb 22.

Template-Based Method for Conformation Generation and Scoring for Congeneric Series of Ligands.

J Chem Inf Model. 2019 Jun 24;59(6):2690-2701. doi: 10.1021/acs.jcim.9b00032. Epub 2019 May 9.

Cryo-EM for Small Molecules Discovery, Design, Understanding, and Application.

Cell Chem Biol. 2018 Nov 15;25(11):1318-1325. doi: 10.1016/j.chembiol.2018.07.006. Epub 2018 Aug 9.

引用本文的文献

Nuclear magnetic resonance free ligand conformations and atomic resolution dynamics.

Magn Reson (Gott). 2021 Jun 23;2(1):489-498. doi: 10.5194/mr-2-489-2021. eCollection 2021.

2,5-disubstituted bicyclo[2.1.1]hexanes as rigidified cyclopentane variants.

Chem Sci. 2023 Jul 12;14(30):8070-8075. doi: 10.1039/d3sc02695g. eCollection 2023 Aug 2.

NMR spectroscopy in drug discovery and development: Evaluation of physico-chemical properties.

ADMET DMPK. 2019 Dec 11;7(4):242-251. doi: 10.5599/admet.737. eCollection 2019.

Relating Conformational Equilibria to Conformer-Specific Lipophilicities: New Opportunities in Drug Discovery.

Angew Chem Int Ed Engl. 2022 Feb 7;61(7):e202114862. doi: 10.1002/anie.202114862. Epub 2021 Dec 29.

Identification of 13 Guanidinobenzoyl- or Aminidinobenzoyl-Containing Drugs to Potentially Inhibit TMPRSS2 for COVID-19 Treatment.

Int J Mol Sci. 2021 Jun 30;22(13):7060. doi: 10.3390/ijms22137060.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Experimental free ligand conformations: a missing link in structure-based drug discovery.

Future Med Chem. 2019 Jan;11(2):79-82. doi: 10.4155/fmc-2018-0339. Epub 2019 Jan 16.

Mass spectrometry for fragment screening.

Essays Biochem. 2017 Nov 8;61(5):465-473. doi: 10.1042/EBC20170071.

Counting on Fragment Based Drug Design Approach for Drug Discovery.

Curr Top Med Chem. 2018;18(27):2284-2293. doi: 10.2174/1568026619666181130134250.

NMR spectroscopy: the swiss army knife of drug discovery.

J Biomol NMR. 2020 Nov;74(10-11):509-519. doi: 10.1007/s10858-020-00330-0. Epub 2020 Jul 2.

NMR in structure-based drug design.

Essays Biochem. 2017 Nov 8;61(5):485-493. doi: 10.1042/EBC20170037.

Fragment-based lead discovery and design.

J Chem Inf Model. 2014 Mar 24;54(3):693-704. doi: 10.1021/ci400731w. Epub 2014 Feb 19.

The conformational musings of a medicinal chemist.

Drug Discov Today. 2014 Mar;19(3):320-5. doi: 10.1016/j.drudis.2013.10.016. Epub 2013 Oct 31.

The use of small-molecule structures to complement protein-ligand crystal structures in drug discovery.

Acta Crystallogr D Struct Biol. 2017 Mar 1;73(Pt 3):240-245. doi: 10.1107/S2059798317000675. Epub 2017 Feb 22.

Template-Based Method for Conformation Generation and Scoring for Congeneric Series of Ligands.

J Chem Inf Model. 2019 Jun 24;59(6):2690-2701. doi: 10.1021/acs.jcim.9b00032. Epub 2019 May 9.

Cryo-EM for Small Molecules Discovery, Design, Understanding, and Application.

Cell Chem Biol. 2018 Nov 15;25(11):1318-1325. doi: 10.1016/j.chembiol.2018.07.006. Epub 2018 Aug 9.

引用本文的文献

Nuclear magnetic resonance free ligand conformations and atomic resolution dynamics.

Magn Reson (Gott). 2021 Jun 23;2(1):489-498. doi: 10.5194/mr-2-489-2021. eCollection 2021.

2,5-disubstituted bicyclo[2.1.1]hexanes as rigidified cyclopentane variants.

Chem Sci. 2023 Jul 12;14(30):8070-8075. doi: 10.1039/d3sc02695g. eCollection 2023 Aug 2.

NMR spectroscopy in drug discovery and development: Evaluation of physico-chemical properties.

ADMET DMPK. 2019 Dec 11;7(4):242-251. doi: 10.5599/admet.737. eCollection 2019.

Relating Conformational Equilibria to Conformer-Specific Lipophilicities: New Opportunities in Drug Discovery.

Angew Chem Int Ed Engl. 2022 Feb 7;61(7):e202114862. doi: 10.1002/anie.202114862. Epub 2021 Dec 29.

Identification of 13 Guanidinobenzoyl- or Aminidinobenzoyl-Containing Drugs to Potentially Inhibit TMPRSS2 for COVID-19 Treatment.

Int J Mol Sci. 2021 Jun 30;22(13):7060. doi: 10.3390/ijms22137060.